US Edition
Published • loading... • Updated
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
Summary by Insight Partners
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
NIJMEGEN, Netherlands, April 17, 2026 /PRNewswire/ — ScreenPoint Medical, a leader in artificial intelligence solutions for breast cancer detection and risk assessment, today announced $14 million in new funding from existing investors, global software investor Insight Partners and Siemens Healthineers, in addition to $2 million in non-dilutive research grants. The investment reflects continued support from ScreenPoint Medical’s long-term partne…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
